Success Stories: EB-1A Approved for a Research Associate in the Field of Life Science
Client’s Testimonial:
Thank you very much for all your help! [...] You are very professional and responsible! I will surely recommend your law firm on MITBBS and my friends!! Thanks a lot!!!
We Received EB1-A (Alien of Extraordinary Ability) Approval on March 9th, 2015 for a Research Associate in the Field of Life Science (Approval Notice)
Position at the Time of Case Filing: Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 9th, 2015
Processing Time: 25 Days (10 days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was a Research Associate in the field of Life Science. Her specialized research has focused on combating the autoimmune disease known as uveitis, optimizing the conventional gene delivery carrier to improve gene therapy, and applying engineered recombinant human proteins to clinical settings. Her work had resulted in 69 peer-reviewed scientific articles, 5 presentations at national and international conferences, and 1 book chapter. At the time that her case was filed, her publications had been cited at least 423 times by researchers around the world, serving as apparent and objective evidence of her major influence and impact on the field of endeavor, in addition to her sustained international acclaim. She had also reviewed 13 manuscripts for at least 3 distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “The inherent value of [client]’s work lies in the danger of uveitis disease. Uveitis is implicated as the cause of 20% of cases of blindness in the United States. [Client] has contributed a remarkable resource for immunologists, biologists, and ophthalmologists who wish to treat, prevent, and eliminate the threat of uveitis all over the world. Autoimmune disorders are persistent and surprising in their ability to survive. Without [client]’s further research on the subject, I predict that this particularly harmful disease will continue to affect millions worldwide.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Life Science, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 25 days.